Key decision-making factors for human papillomavirus (HPV) vaccine program introduction in low-and-middle-income-countries: Global and national stakeholder perspectives

Dominique Guillaumea International Vaccine Access Center, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA;b Jhpiego, A Johns Hopkins University Affiliate, Baltimore, MD, USA;c School of Nursing, Johns Hopkins University, Baltimore, MD, USAView further author information

Dur-e-Nayab Waheedd Center for the Evaluation of Vaccination, University of Antwerp, Antwerp, Belgium;e HPV Prevention and Control Board, University of Antwerp, Antwerp, BelgiumView further author information

Meike Schlieffa International Vaccine Access Center, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA;f Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USAView further author information

Kirthini Muralidharana International Vaccine Access Center, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USAView further author information

Alex Vorstersd Center for the Evaluation of Vaccination, University of Antwerp, Antwerp, Belgium;e HPV Prevention and Control Board, University of Antwerp, Antwerp, BelgiumView further author information

Rupali Limayea International Vaccine Access Center, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA;f Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA;g Department of Health, Behavior & Society, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA;h Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USACorrespondence[email protected]

https://orcid.org/0000-0002-3883-9720 View further author information

Key decision-making factors for human papillomavirus (HPV) vaccine program introduction in low-and-middle-income-countries: Global and national stakeholder perspectives

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Key decision-making factors for human papillomavirus (HPV) vaccine program introduction in low-and-middle-income-countries: Global and national stakeholder perspectives

Reprints and Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date